The evidence against pharmacy benefit managers, or PBMs, has been piling up. Congress and multiple state legislatures have held hearings revealing how the anti-consumer practices of these health insurance corporate middlemen are driving up out-of-pocket prescription drug costs. The Federal Trade Commission issued a report condemning PBM pricing manipulations. Media reports have detailed how these middlemen mark up […]
Author Archives: Mark Blum
Mark Blum is the managing director of the PBM Accountability Project. He wrote this for InsideSources.com.